Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
100.34
+1.96 (1.99%)
At close: May 15, 2025, 4:00 PM
100.86
+0.52 (0.52%)
After-hours: May 15, 2025, 7:00 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
According to 23 professional analysts, the 12-month price target for Gilead Sciences stock ranges from a low of $80 to a high of $140. The average analyst price target of $109 forecasts a 8.63% increase in the stock price over the next year.
Price Target: $109.00 (+8.63%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
Buy | 11 | 12 | 12 | 12 | 13 | 13 |
Hold | 12 | 11 | 11 | 11 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 26 | 26 | 27 | 27 | 26 | 25 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $132 → $125 | Buy | Maintains | $132 → $125 | +24.58% | Apr 25, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $130 → $135 | Buy | Maintains | $130 → $135 | +34.54% | Apr 25, 2025 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 25, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $125 | Buy | Initiates | $125 | +24.58% | Apr 22, 2025 |
JP Morgan | JP Morgan | Buy Maintains $120 → $130 | Buy | Maintains | $120 → $130 | +29.56% | Mar 27, 2025 |
Financial Forecast
Revenue This Year
29.30B
from 28.75B
Increased by 1.88%
Revenue Next Year
30.45B
from 29.30B
Increased by 3.95%
EPS This Year
8.11
from 0.38
Increased by 2,033.40%
EPS Next Year
8.57
from 8.11
Increased by 5.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 30.8B | 33.5B | 35.6B | ||
Avg | 29.3B | 30.5B | 31.9B | ||
Low | 27.8B | 28.4B | 28.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 7.3% | 14.3% | 16.9% | ||
Avg | 1.9% | 3.9% | 4.6% | ||
Low | -3.4% | -3.2% | -5.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.56 | 9.53 | 10.74 | ||
Avg | 8.11 | 8.57 | 9.09 | ||
Low | 7.60 | 6.34 | 6.89 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2,152.0% | 17.6% | 25.4% | ||
Avg | 2,033.4% | 5.7% | 6.1% | ||
Low | 1,898.7% | -21.8% | -19.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.